Nearly all cancer drug targets are also found on many healthy cells. Scientists created a "biological computer" to get around this tricky issue. With a 'biological computer,' scientists look to target cancer while sparing healthy cells By Angus Chen Adobe Inside an engineered virus, scientists packaged a programmable genetic circuit that uses multiple targets to build a cancer cell's profile. Read More STAT+: The biotech scorecard for the first quarter: 19 stock-moving events to watch By Adam Feuerstein Ryan Pierse/Getty Images Get ready for readouts on Abbvie's cystic fibrosis treatment, Gilead's newly acquired cancer drug Trodelvy, and much more. Read More Opinion: Will the Biden administration use 'march-in' to protect prostate cancer patients from excessive drug prices? By Peter Arno and Robert Sachs and Kathryn Ardizzone Anne Weston/Francis Crick Institute/Wellcome A petition asking HHS to exercise lawful march-in rights for the prostate cancer drug Xtandi has languished since 2019. It needs action. Read More Sponsor content by STAT Events STAT@JPM: Will 2022 bring biotech renewal? Come explore what's happening in biotech, virtually, with STAT's Adam Feuerstein. On Jan. 11, he'll convene experts and reporters to discuss the need-to-know news from biotech's biggest confab, and ask what it all means for the year ahead. STAT+: How Brigham Health helped create a Chinese hospital for elites — and almost nobody came By Deirdre Fernandes, Rebecca Ostriker, Liz Kowalczyk and Spotlight editor Patricia Wen — The Boston Globe Where there was once so much ambition, there are now critics asking questions: Was this the right project for a prestigious Boston hospital? Read More Opinion: Nuclear Regulatory Commission's foot-dragging on patient irradiation suggests regulatory capture By Daniel Fass FRED TANNEAU/AFP via Getty Images The Nuclear Regulatory Commission's reluctance to change a reporting rule on extravasation is at odds with science and patient safety. Read More Tuesday, January 4, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments